Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | -206,439 | 0 | N/A | -363,526 |
| Depreciation Amortization | 0 | 7,425 | 0 | N/A | 9,253 |
| Other Working Capital | 0 | -44,702 | 0 | N/A | 80,040 |
| Other Operating Activity | 0 | 59,918 | 0 | 0 | 114,341 |
| Operating Cash Flow | $0 | $-183,798 | $0 | $N/A | $-159,892 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 3 | 0 | N/A | 0 |
| Net Acquisitions | 0 | 25 | 0 | N/A | 0 |
| Other Investing Activity | 0 | 14,411 | 0 | 0 | 66,459 |
| Investing Cash Flow | $0 | $14,439 | $0 | $N/A | $66,459 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 1,066 | 0 | 0 | 6,141 |
| Financing Cash Flow | $0 | $1,066 | $0 | $N/A | $6,141 |
| Exchange Rate Effect | 0 | 11,896 | 0 | N/A | 56,429 |
| Beginning Cash Position | 0 | 466,311 | 0 | N/A | 510,879 |
| End Cash Position | 0 | 309,914 | 0 | N/A | 480,016 |
| Net Cash Flow | $0 | $-156,397 | $0 | $N/A | $-30,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -183,798 | 0 | N/A | -159,892 |
| Free Cash Flow | 0 | -183,798 | 0 | 0 | -159,892 |